Chemical formula: C₁₂H₆N₂O₈SSr₂ Molecular mass: 513.49 g/mol PubChem compound: 6918182
Strontium ranelate is indicated for:
Population group: only adults (18 years old or older)
Treatment of severe osteoporosis:
at high risk of fracture, for whom treatment with other medicinal products approved for the treatment of osteoporosis is not possible due to, for example, contraindications or intolerance. In postmenopausal women, strontium ranelate reduces the risk of vertebral and hip fractures.
The decision to prescribe strontium ranelate should be based on an assessment of the individual patient’s overall risks.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Strontium ranelate is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.